News

Corbus higher as FDA issues another fast track tag for lead asset

Corbus Pharma (CRBP) stock rises as the company gains a new Fast Track designation for its lead drug, CRB-701 in head and ...

FDA Grants Fast Track Designation to Corbus Pharmaceuticals’ Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma

Dose optimization data from the Phase 1/2 study to be presented next month at ESMO 2025Second Fast Track designation granted by FDA for ...
TipRanks on MSN

Corbus Pharmaceuticals receives Fast Track designation for CRB-701

Corbus Pharmaceuticals (CRBP) announced that the U.S. Food and Drug Administration has granted Fast Track designation to CRB-701 for the treatment ...